Tag: Abbott
Abbott opens new facility for sensors, CGMs
November 18, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, Ireland, part of its €440 million investment in the country. The new 30,000-square-meter Kilkenny facility is producing FreeStyle Libre 3 sensors and the latest generation in Abbott’s continuous glucose monitoring portfolio for people living with diabetes. "This is our latest commitment to providing innovative care and supporting...
FDA says OK to leave FreeStyle Libre CGMs on for imaging
October 30, 2024HME News Staff
ABBOTT PARK, Ill. – Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT scans and MRIs. The U.S. Food and Drug Administration has cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied CGM sensors approved for these screenings. "For people with diabetes, especially those using insulin, removing a CGM...
In brief: Apple Watch, SOAR Act, Abbott Lingo, MAC consolidation
September 11, 2024HME News Staff
CUPERTINO, Calif. – Apple on Sept. 9 unveiled Apple Watch Series 10, which among other things, features a new sleep apnea feature.
Building on the intelligent health features already available to track key overnight metrics such as heart rate, respiratory rate and wrist temperature, the watch’s new sleep apnea feature can help identify signs of sleep apnea, the company says, by using the accelerometer to monitor small movements at the wrist that are associated with interruptions...
Abbott recalls certain sensors
September 9, 2024HME News Staff
ABBOTT PARK, Ill. - Abbott has issued a recall for certain FreeStyle Libre 3 sensors due to a risk for inaccurate high glucose readings. On July 24, the company sent all affected customers an urgent medical device recall recommending they, among other things, immediately discontinue use and dispose of any affected sensors, and request a replacement for any affected seniors. Abbott initiated the recall after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose...
Abbott launches consumer biowearable
September 9, 2024HME News Staff
ABBOTT PARK, Ill. - Abbott has announced the U.S. availability of Lingo, the company’s first glucose monitoring system available without prescription.
The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness, the company says.
"There is a great deal of interest in tracking biomarkers that provide insights into one's health and wellness that were previously undetectable using the trackers available...
In brief: e-prescribe push, PBM guardrails & data collection efforts
September 6, 2024HME News Staff
WASHINGTON – AAHomecare is bringing together a group of e-prescribing vendors to develop resources, including an upcoming webinar, to educate suppliers and other key audiences.
In the group: Brightree, DMEscripts, Parachute Health and Tomorrow Health.
“Our board members and industry partners have invested heavily in e-prescribing transformation as a means to lower operating costs and to improve delivery of care and patient safety for all providers,” said John Brady,...
In brief: Abbott, Medtronic partner & InfuSystem, Smith+Nephew partner
August 9, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott will enter a global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's FreeStyle Libre technology and Medtronic's automated insulin delivery (AID) and smart insulin pen systems.
The integration of Abbott's CGM sensor with Medtronic's AID algorithms will enable automatic adjustments of insulin to keep glucose in range, the companies say.
"This partnership pairs...
Abbott, Medtronic partner on diabetes system
August 7, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott will enter a global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's FreeStyle Libre technology and Medtronic's automated insulin delivery (AID) and smart insulin pen systems.
The integration of Abbott's CGM sensor with Medtronic's AID algorithms will enable automatic adjustments of insulin to keep glucose in range, the companies say.
"This partnership pairs...
Abbott, Tandem integrate
January 9, 2024HME News Staff
ABBOTT PARK, Ill., and SAN DIEGO – Abbott and Tandem Diabetes Care have announced that the t:slim X2 insulin pump with Control-IQ technology is the first automated insulin delivery system to integrate with the newly available FreeStyle Libre 2 Plus sensor. For the first time, FreeStyle Libre technology users in the United States are now able to experience the therapeutic benefits of a hybrid closed-loop system that helps predict and prevent high and low blood sugar. “Tandem’s leadership...
Abbott, WeightWatchers team up on new app
September 19, 2023HME News Staff
ABBOTT PARK, Ill., and NEW YORK – Abbott and WeightWatchers have announced the availability of a connected app to help people living with diabetes understand how food and activity impact their glucose levels. WW members who follow the WW Diabetes-Tailored Plan can now access their glucose data from Abbott’s FreeStyle Libre 2, a continuous glucose monitoring system, within their WW app. "Clinical data shows that healthy weight loss leads to a reduction of average glucose, which is important...